A Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients With JRA
Public ClinicalTrials.gov record NCT00652925. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Double-Blind, Multicenter, Active Controlled Parallel Group Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients With JRA
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To study Celebrex versus naproxen to see if it decreases symptoms of juvenile arthritis such as pain and swelling.
Study identification
- NCT ID
- NCT00652925
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 225 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 2 Years to 18 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2002 (Type not available)
- Primary completion
- Apr 2004 (Actual)
- Completion
- Apr 2005 (Actual)
- Last update posted
- May 30, 2008
2002 – 2005
United States locations
- U.S. sites
- 31
- U.S. states
- 14
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | San Diego | California | 92123 | — |
| Pfizer Investigational Site | Hartford | Connecticut | 06106 | — |
| Pfizer Investigational Site | Delray Beach | Florida | 33484 | — |
| Pfizer Investigational Site | Miami | Florida | 33155 | — |
| Pfizer Investigational Site | St. Petersburg | Florida | 33701 | — |
| Pfizer Investigational Site | Chicago | Illinois | 60614 | — |
| Pfizer Investigational Site | Chicago | Illinois | 60637 | — |
| Pfizer Investigational Site | Chicago | Illinois | 60649 | — |
| Pfizer Investigational Site | Glenview | Illinois | 60025 | — |
| Pfizer Investigational Site | Hinsdale | Illinois | 60521 | — |
| Pfizer Investigational Site | Merrillville | Indiana | 46410 | — |
| Pfizer Investigational Site | New Orleans | Louisiana | 70118 | — |
| Pfizer Investigational Site | Boston | Massachusetts | 02115 | — |
| Pfizer Investigational Site | Worcester | Massachusetts | 01610 | — |
| Pfizer Investigational Site | Omaha | Nebraska | 68178 | — |
| Pfizer Investigational Site | Livingston | New Jersey | 07039 | — |
| Pfizer Investigational Site | New Hyde Park | New York | 11040 | — |
| Pfizer Investigational Site | New York | New York | 10032 | — |
| Pfizer Investigational Site | Tulsa | Oklahoma | 74133 | — |
| Pfizer Investigational Site | Tulsa | Oklahoma | 74135 | — |
| Pfizer Investigational Site | Portland | Oregon | 97210 | — |
| Pfizer Investigational Site | Portland | Oregon | 97227-1623 | — |
| Pfizer Investigational Site | Portland | Oregon | 97232 | — |
| Pfizer Investigational Site | Altoona | Pennsylvania | 16601 | — |
| Pfizer Investigational Site | Altoona | Pennsylvania | 16602 | — |
| Pfizer Investigational Site | Duncansville | Pennsylvania | 16635 | — |
| Pfizer Investigational Site | Hershey | Pennsylvania | 17033 | — |
| Pfizer Investigational Site | Johnstown | Pennsylvania | 15904 | — |
| Pfizer Investigational Site | Lancaster | Pennsylvania | 17604 | — |
| Pfizer Investigational Site | Milwaukee | Wisconsin | 53201 | — |
| Pfizer Investigational Site | Milwaukee | Wisconsin | 53226-0509 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00652925, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 30, 2008 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00652925 live on ClinicalTrials.gov.